|
|
Volumn 10, Issue 1, 2007, Pages 31-35
|
|
Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ALGORITHM;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DRUG COMBINATION;
DYSLIPIDEMIA;
HUMAN;
METABOLISM;
REVIEW;
RISK FACTOR;
ALGORITHMS;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL, LDL;
CLINICAL TRIALS;
CORONARY DISEASE;
DRUG THERAPY, COMBINATION;
DYSLIPIDEMIAS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
RISK FACTORS;
|
|
EID: 33847697753
PISSN: 1520037X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1520-037X.2007.05662.x Document Type: Review |
|
Times cited : (5)
|
|
References (23)
|
